Virtu Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$386K Buy
+1,023
New +$357K 0.01% 642
2026
Q1
– Sell
-2,218
Closed -$672K – 1655
2025
Q4
$672K Buy
+2,218
New +$692K 0.03% 484
2024
Q3
– Sell
-1,494
Closed -$408K – 1383
2024
Q2
$408K Buy
+1,494
New +$435K 0.03% 499
2024
Q1
– Sell
-1,022
Closed -$330K – 1425
2023
Q4
$330K Buy
+1,022
New +$320K 0.03% 570
2022
Q4
– Sell
-3,010
Closed -$1.26M – 1623
2022
Q3
$1.26M Buy
3,010
+1,576
+110% +$786K 0.12% 147
2022
Q2
$710K Buy
+1,434
New +$747K 0.06% 284
2020
Q3
– Sell
-1,653
Closed -$746K – 1071
2020
Q2
$746K Buy
+1,653
New +$729K 0.09% 254
2019
Q4
– Sell
-818
Closed -$272K – 1445
2019
Q3
$272K Buy
+818
New +$267K 0.02% 807
2019
Q2
– Sell
-5,414
Closed -$1.66M – 1467
2019
Q1
$1.66M Buy
+5,414
New +$1.46M 0.09% 179
2018
Q4
– Sell
-944
Closed -$295K – 1558
2018
Q3
$295K Sell
944
-236
-20% -$73.3K 0.02% 859
2018
Q2
$340K Buy
+1,180
New +$326K 0.02% 1065
2018
Q1
– Sell
-4,324
Closed -$1.03M – 1963
2017
Q4
$1.03M Buy
4,324
+1,994
+86% +$483K 0.05% 424
2017
Q3
$518K Buy
+2,330
New +$524K 0.03% 906

Other funds holding BIO

Virtu Financial's BIO Position: Q3 2026 in Review

Virtu Financial opened a new position in Bio-Rad Laboratories Class A (BIO) in Q3 2026: 1,023 shares worth $386K. The stake represents 0.01% of the portfolio and ranks #642 among its holdings. This is a return to the name: Virtu Financial previously reported a position in BIO as recently as Q4 2025.

Virtu Financial first reported a position in BIO in Q3 2017 and has held it in 13 quarters since. The position peaked at $1.66M in Q1 2019. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Virtu Financial held 1,023 shares of Bio-Rad Laboratories Class A worth $386K as of Q3 2026.
  • Bio-Rad Laboratories Class A was a new Virtu Financial position in Q3 2026.
  • Bio-Rad Laboratories Class A made up 0.01% of Virtu Financial's portfolio in Q3 2026, its #642 holding.
  • Virtu Financial first reported a position in Bio-Rad Laboratories Class A in Q3 2017 and has held it in 13 quarters since.
  • Virtu Financial's Bio-Rad Laboratories Class A position peaked at $1.66M in Q1 2019.
  • 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.